US Patent Issued to Inserm (Institut National De La Sante Et De La Recherche Medicale), UNIVERSITE D'AIX MARSEILLE, UNIVERSITE DE BORDEAUX, REGENXBIO, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) on Oct. 27 for "Compounds for use in the treatment of epilepsy" (French, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,466, issued on Oct. 27, was assigned to Inserm (Institut National De La Sante Et De La Recherche Medicale) (Paris), UNIVERSITE D'AIX MARSEILLE (Marseilles, France), UNIVERSITE DE BORDEAUX (Bordeaux, France), REGENXBIO INC. (Rockville, Md.) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris).

"Compounds for use in the treatment of epilepsy" was invented by Celine Boileau (Marseilles, France), Valerie Crepel (Marseilles, France), Severine Deforges (Bruges, France), Julie Masante (Saint Jean d'illac, France), Christophe Mulle (Pessac, France), Angelique Peret (Marseilles, France), Olivier Danos (Rockville, Md.) and Andrew Mercer (Rockville, Md.).

According to the abstrac...